QuidelOrtho reports Q1 adjusted EPS 74c, consensus 59c

Reports Q1 revenue $693M, consensus $691.9M. “We delivered solid first quarter performance driven by growth in our Labs business and the strength of our recurring revenue business model,” said Brian Blaser, President and Chief Executive Officer, QuidelOrtho (QDEL). “Our ongoing operational improvement initiatives contributed meaningfully to our results. We are proactively addressing macroenvironment operating challenges and maintaining our full-year 2025 financial guidance based on our current business outlook. As we look ahead, we remain committed to commercial excellence, margin expansion, and supporting our customers and the patients who rely on our products.”